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Abstract 
 
Nucleoredoxin is a redox sensitive protein recently shown to be involved in the 
Wnt/β-catenin pathway through binding dishevelled. When Wnt is present, dishevelled 
prevents a destruction complex from degrading β-catenin. This facilitates the 
translocation of β-catenin into the nucleus where it binds to TCF-LEF to impart changes 
in gene expression. This study used mouse F9 cells as a model to examine whether or not 
nucleoredoxin is involved in augmenting the Wnt/β-catenin signaling required for 
extraembryonic endoderm differentiation. It was found that nucleoredoxin and three 
dishevelled isoforms were present in F9 cells. Furthermore, nucleoredoxin was found to 
bind to dishevelled-2, and when cells were treated with an oxidizing agent this interaction 
diminished. Lastly, when nucleoredoxin expression was knocked down, F9 cells 
differentiated into extraembryonic endoderm. Together, the data would indicate that the 
Wnt/β-catenin signaling pathway obligatory for extraembryonic endoderm differentiation 
is redox regulated at the level of nucleoredoxin.  
 
 
 
Keywords 
F9, Primitive endoderm, Parietal endoderm, Extraembryonic endoderm, ROS, H2O2, 
Differentiation, Dishevelled, Nucleoredoxin 
iii 
 
 
 
Acknowledgements 
 First and foremost I would like to thank my supervisor Dr. Greg Kelly for his 
support and guidance. His endless encouragement and wisdom showed me how to 
become a confident and devoted researcher. He was supportive throughout my project 
and I am greatly appreciative for the experiences I have gained during my time in his lab.    
 I would like to thank the past and present members of the Kelly Lab in particular 
Greg Golenia, Steven Sun and Shaun Symons. I would like to extend a special thanks to 
Jason Hwang for his continuous support and guidance. His advice and valuable input on 
my research were essential throughout my project.    
 I also would like to thank my advisors Dr. Robert Cumming and Dr. Jim 
Karagiannis for their advice and technical assistance with this project. I would like to 
further thank Dr. Cumming for his extended guidance and for the use of his equipment. I 
would also like to thank Dr. Damjanovski for his support and use of his equipment.  
 Finally, I would like to thank current and previous members of the Cumming and 
Damjanovski labs including Mario Cepeda, Mark Fox, Michelle Nieuwesteeg, Tyler 
Cann and Jordan Epstein for their helpful advice, sharing of reagents and friendships 
throughout my project.  
 
 
  
iv 
 
 
 
Table of Contents 
Title Page .............................................................................................................................i 
CERTIFICATE OF EXAMINATION ........................................................................... ii 
Abstract .............................................................................................................................. iii 
Acknowledgements ............................................................................................................ iv 
Table of Contents.................................................................................................................v 
List of Figures .................................................................................................................. viii 
List of Abbreviations ......................................................................................................... ix 
Chapter 1 ............................................................................................................................. 1 
1 Introduction ...................................................................................................................... 1 
1.1 Early mouse development ............................................................................................. 1 
1.2 The mouse F9 teratocarinoma cell line ......................................................................... 4 
1.3 Canonical Wnt/β-catenin signaling ............................................................................... 5 
1.4 Reactive Oxygen Species .............................................................................................. 6 
1.5 Nucleoredoxin and Dishevelled .................................................................................... 9 
1.6 Role of Nucleoredoxin in development and rationale for further research ................. 11 
1.7 Objectives and Hypothesis .......................................................................................... 12 
Chapter 2 ........................................................................................................................... 16 
2 Materials and Methods ................................................................................................... 16 
2.1 Cell Culture ................................................................................................................. 16 
2.2 Reverse Transcription PCR and Quantitative Reverse Transcription PCR ................ 16 
2.3 Immunoblot Analysis .................................................................................................. 18 
v 
 
 
 
2.4 Co-Immunoprecipitation ............................................................................................. 19 
2.5 sh-NRX construct and Knockdown ............................................................................. 20 
2.6 Microscopy ................................................................................................................. 21 
2.7 Statistical Analysis ...................................................................................................... 21 
Chapter 3 ........................................................................................................................... 22 
3 Results ............................................................................................................................ 22 
3.1 RA, H2O2 and db-cAMP induce differentiation of F9 cells ........................................ 22 
3.2 Antioxidants attenuate RA-induced differentiation .................................................... 25 
3.3 Dvl-1, Dvl-2 and Dvl-3 mRNA expression profiles remain constant after RA 
treatment ........................................................................................................................... 26 
3.4 Dvl-1, Dvl-2 and Dvl-3 protein expression profiles remain constant after RA 
treatment ........................................................................................................................... 29 
3.5 NRX mRNA expression profile remains constant after RA treatment ........................ 33 
3.6 NRX protein expression profile remains constant after RA treatment ....................... 38 
3.7 Interaction between NRX and Dvl-2 is redox regulated ............................................. 38 
3.8 NRX knockdown differentiates F9 cells to PrE .......................................................... 44 
3.9 NRX knockdown plus db-cAMP differentiates F9 cells to PE ................................... 48 
Chapter 4 ........................................................................................................................... 55 
4 Discussion ...................................................................................................................... 55 
4.1 Increase in ROS is necessary for ExE differentiation ................................................. 57 
4.2 Dvl and NRX are not RA responsive in F9 cells ........................................................ 58 
4.3 Redox regulated interaction between NRX and Dvl-2 ............................................... 60 
4.4 NRX inhibits Wnt signaling induced ExE differentiation .......................................... 61 
4.5 Relationship of NRX and Nox point to future research in F9 cells ............................ 62 
Literature Cited ................................................................................................................. 66 
vi 
 
 
 
Curriculum Vitae .............................................................................................................. 70 
 
vii 
 
 
 
List of Figures 
 
Figure 1.1 Specified cells of the inner cell mass of the blastocyst differentiate first to 
primitive endoderm and then to parietal and visceral endoderm. ....................................... 2 
Figure 1.2 Canonical Wnt/β-catenin signaling in F9 cells induces differentiation to PrE . 7 
Figure 1.3 Increase in ROS causes NRX dissociation from Dvl and enhances canonical 
Wnt signaling. ................................................................................................................... 14 
Figure 3.1 RA and H2O2 induce morphological changes and markers of primitive 
endoderm; with the addition of db-cAMP cells become competent to form parietal 
endoderm. .......................................................................................................................... 23 
Figure 3.2 Antioxidants NAC and Vitamin C attenuate RA-induced differentiation in F9 
cells. .................................................................................................................................. 27 
Figure 3.3 Dvl-1, Dvl-2 and Dvl-3 mRNA levels are not affected by RA treatment. ...... 30 
Figure 3.4 Dvl-1, Dvl-2 and Dvl-3 protein levels are not affected by RA treatment. ...... 34 
Figure 3.5 NRX mRNA levels are not affected by RA treatment. ................................... 36 
Figure 3.6 NRX protein levels are not RA responsive. .................................................... 39 
Figure 3.7 The interaction between NRX and Dvl-2 in F9 cells is redox-dependent. ...... 42 
Figure 3.8 NRX knockdown increased endo-A cytokeratin levels indicative of 
extraembryonic endoderm differentiation. ........................................................................ 46 
Figure 3.9 F9 cells transfected with sh-NRX and treated with db-cAMP form parietal 
endoderm. .......................................................................................................................... 49 
Figure 4.1 A model for the differentiation of extraembryonic endoderm in F9 cells ....... 64 
viii 
 
 
 
List of Abbreviations 
̊C  Degrees Celsius 
μg  microgram 
μL  microliter 
μm  micrometer  
ANOVA Analysis Of Variance 
APC  Adenomatous Polyposis Coli 
ATCC  American Type Culture Collection 
β  beta 
BSA  Bovine Serum Albumin 
cDNA  complimentary Deoxyribonucleic Acid 
CK1  Casein Kinase 1 
CO2  Carbon Dioxide 
Ct  Cycle threshold 
CXXC  Cysteine-X-X-Cysteine 
db-cAMP dibutyryl cyclic Adenosine Monophosphate 
DMEM Dulbecco’s Modified Eagle’s Medium 
DMSO  Dimethyl Sulfoixde 
DPI  Diphenyleneiodonium 
ix 
 
 
 
DTT  Dithiothreitol 
Dvl  Dishevelled 
EMT  Epithelial-Mesenchymal Transition 
ExE  Extraembryonic Endoderm 
F9  Mouse F9 Embryonal Carcinoma (Teratocarinoma) 
FBS  Fetal Bovine Serum 
Fig   Figure 
Fzd  Frizzled 
GSK-3β Glycogen Synthase Kinase 3 beta 
h  hours 
H2O2  Hydrogen Peroxide 
HRP  Horseradish Peroxidase  
HSD  Honestly Significant Difference 
ICM  Inner Cell Mass 
IgG  Immunoglobulin G 
JNK  c-Jun-N-terminal Kinase 
kDa  Kilodalton 
LRP  Lipoprotein-receptor Related Protein 
mins  minutes  
x 
 
 
 
M  Molar 
mM  millimolar 
MMTV Mouse Mammary Tumor Virus 
mRNA  messenger Ribonucleic Acid 
NAC  N-Acetyl Cysteine 
NIH3T3 Mouse embryonic fibroblast cell line 
nM  nanomolar 
NOX  NADPH Oxidase  
NP-40  Nonyl Phenoxypolyethoxylethanol 
NRX  Nucleoredoxin 
PAGE  Polyacrylamide Gel Electrophoresis 
PBS  Phosphate Buffered Saline 
PCP  Planar Cell Polarity 
PE  Parietal Endoderm 
PrE  Primitive Endoderm 
p-value            probability value 
qRT-PCR quantitative Reverse Transcription Polymerase Chain Reaction 
RA  all trans Retinoic Acid 
RNAi  Ribonucleic Acid interference  
xi 
 
 
 
xii 
 
ROS  Reactive Oxygen Species 
RT-PCR Reverse Transcription Polymerase Chain Reaction 
s  seconds 
SDS   Sodium Dodecyl Sulphate 
shRNA small hairpin Ribonucleic Acid 
SPSS  Statistical Package for the Social Sciences 
TBS  Tris Buffered Saline 
TBS-T  Tris Buffered Saline with Tween-20 
TCF-LEF T-Cell specific transcription Factor-Lymphoid Enhancer binding Factor 
TM  Thrombomodulin  
TROMA-1 Trophectoderm Monoclonal Antibody-1 
TRX  Thioredoxin 
VE  Visceral Endoderm 
WNT  Wingless/ MMTV Integrated site 
1 
 
Chapter 1  
 
1 Introduction 
  
1.1 Early mouse development
 
During early mouse embryonic development, the fertilized egg undergoes a series of 
mitotic divisions leading to the development of the morula [1]. Cells of the morula give 
rise to one of two blastocyst lineages: trophectoderm or inner cell mass (ICM). The 
trophectoderm arises from the outer cells of the blastocyst and is responsible for the 
development of the embryonic placenta. The inner cells of the blastocyst form the ICM, 
which further differentiates into the epiblast, giving rise to the embryo proper, or to 
primitive endoderm (PrE) [1, 2] (Fig 1.1).  
PrE further differentiates to parietal and visceral endoderms (PE and VE), which form 
the parietal and visceral yolk sacs, respectively. The cells of the PrE, PE and VE, 
collectively known as extraembryonic endoderm (ExE), are important for embryonic 
patterning as well as for providing nutrients and signaling molecules to the developing 
embryo [1, 3]. This differentiation of the ICM first to PrE and then to PE and VE is one 
of the earliest epithelial-to-mesenchymal transitions (EMT) in the developing mouse 
embryo. EMTs are characterized by the loss of E-cadherin expression, which eliminates 
stable junctions between the cells, and allows for the development of  a morphological 
state suitable for cellular migration [4]. Analysing EMTs can provide insight into 
developmental processes as well as tumour progression and cancer metastasis.  
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 Figure 1.1 Specified cells of the inner cell mass of the blastocyst differentiate first to 
primitive endoderm and then to parietal and visceral endoderm.  In early mouse 
embryonic development, the blastocyst gives rise to cells of the inner cell mass (ICM). 
The ICM differentiates to either the epiblast, giving rise to the embryo proper, or to 
primitive endoderm (PrE). PrE further differentiates to parietal and visceral endoderms 
(PE and VE), which form the parietal and visceral yolk sacs, respectively (Image 
modified from [5]). 
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1.2 The mouse F9 teratocarinoma cell line
 
Studying EMTs, and in particular the transition to ExE, is difficult to study in vivo. 
Fortunately, researchers have been able to utilize the mouse F9 teratocarinoma cell line as 
a model to mimic this process in vitro [6, 7]. The F9 cell line was established by grafting 
6-day old embryos into host testes of the mouse 129/Sv strain to produce teratomas [8]. 
Normally, these F9 teratocarcinoma cells undergo little differentiation, but when treated 
with retinoic acid (RA), a vitamin A derivative, the cells are induced to form PrE [9].  
RA acts through binding to RA receptors and retinoid X receptors, which act as a 
heterodimer to efficiently bind RA-response elements in the promoter regions of target 
genes and transduce the retinoid signal [10, 11]. F9 cells have proven to be an important 
model for studying RA signaling as they express all known RA receptors. RA-responsive 
genes in F9 cells are numerous and include, but are not limited to, Gata6, FoxA2 and 
Wnt6 [11, 12]. When F9 cells are treated with low concentrations (10-7 M) of RA, 
changes in gene expression and cell morphology lead to the compact cells transitioning to 
a flat appearance as they move apart from one another, a scenario resembling PrE 
formation. Cytokeratin A intermediate filaments are also assembled and these can be 
detected using TROMA-1 (TROphectodermal Monoclonal Antibody) [13, 14]. RA 
signaling is therefore an essential regulator in cell differentiation and proliferation [4, 10]. 
 F9 cells can be further induced to differentiate from PrE to PE by the addition of 
dibutyryl cyclic adenosine monophosphate (db-cAMP) to RA-treated cells. PE in the 
developing mouse embryo is in contact with the maternal blood; therefore PE should 
contain biological characteristics of vascular endothelial cells. Increasing the levels of 
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cAMP in F9 cells causes morphological changes as well as an increase in the secretion of 
tissue-type plasminogen activator and Thrombomodulin (TM), reminiscent of what 
occurs in the PE of mouse embryos [7, 14]. Accordingly, treating cells with RA followed 
by db-cAMP thus recapitulates the EMT of the ICM differentiating into ExE. In this 
study, TROMA-1 will be used as a pan-ExE marker while TM will be used as a marker 
exclusive to PE [13, 14].  
 
 
 1.3 Canonical Wnt/β-catenin signaling
 
Wnts are secreted glycoproteins that play numerous roles in vertebrate development 
including cell proliferation, cell survival, and determining cell fate [15]. In addition to 
development, Wnt pathways are also involved in cancers, neurodegenerative diseases, the 
regulation of bone density, and osteoarthritis [15]. There are nineteen known Wnts in 
vertebrates that signal through three pathways: canonical Wnt/β-catenin, planar cell 
polarity (PCP) or Wnt/Ca2+ pathway. My research focuses on canonical Wnt signaling as 
my lab reported several years ago that RA activates this specific pathway in F9 cells, and 
as a result cells differentiate to form ExE [16]. 
In the canonical Wnt/β-catenin pathway, Wnt binds to one of several seven-
transmembrane Frizzled (Fzd) receptors, and to low-density lipoprotein-receptor related 
protein (LRP) 5/6. The binding of Wnt to its receptor causes Dishevelled (Dvl) to be 
recruited to the plasma membrane where it acts to inhibit a destruction complex 
composed of casein kinase 1 (CK1), glycogen synthase kinase 3 beta (GSK-3β), Axin, 
and the adenomatous polyposis coli tumour suppressor protein (APC).  Disrupting this 
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complex allows β-catenin to accumulate in the cytosol, followed by its subsequent 
translocation into the nucleus where it binds to T-cell-factor lymphoid enhancer factor 
(TCF-LEF) to induce the transcription of Wnt target genes [16]. The regulated activation 
and repression of Wnt target genes, such as Snail1, cyclinD1 and c-Myc, allows for cell 
proliferation and differentiation to PrE [17]. In the absence of Wnt, however, Dvl is not 
recruited to the plasma membrane, and therefore cannot disrupt the destruction complex. 
This results in cytoplasmic β-catenin being ubiquitinated by an E3 ubiquitin ligase and 
targeted for proteasomal destruction (Fig 1.2).  
 
 
1.4 Reactive Oxygen Species  
 
Recently, our lab has found that the RA-induced activation of canonical Wnt 
signaling in F9 cells and subsequent PrE formation is accompanied by increased reactive 
oxygen species (ROS) levels [18]. Not surprisingly, while increasing β-catenin levels is 
sufficient to induce PrE, it has been known for several years that other mechanisms are 
necessary to maintain cells in this state [6]. ROS is a term used to describe various 
species such as superoxides, hydrogen peroxide, and hydroxyl radicals. The most 
common production of ROS are as by-products from the incomplete reduction of oxygen 
through cellular respiration [19, 20]. More recent evidence shows ROS are also produced 
through NADPH oxidases (Nox), a plasma membrane-coupled enzyme complex that 
generates O2- using cytosolic NADPH as an electron donor [19].  
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Figure 1.2 Canonical Wnt/β-catenin signaling in F9 cells induces differentiation to PrE. 
Wnt binds to one of several Frizzled receptors, and to low-density lipoprotein-receptor 
related protein 5/6. This interaction causes Dishevelled (Dvl) to be phosphorylated and 
recruited to the plasma membrane where it acts to inhibit a destruction complex, thereby 
allowing β-catenin to accumulate in the cytosol and subsequently translocate to the 
nucleus where it binds to T-cell-factor lymphoid enhancer factor to induce the 
transcription of Wnt target genes necessary for PrE differentiation. In the absence of Wnt, 
Dvl is not recruited to the plasma membrane, and therefore it is unable to disrupt the 
destruction complex. As a result, β-catenin is targeted for proteasomal destruction. 
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ROS are known to have deleterious effects causing damage to nucleic acids, proteins 
and lipids, however, antioxidants within the cell are able to regulate ROS levels to  
minimize this damage [21-23]. Besides deleterious effects, convincing studies indicate 
that cells use ROS in a beneficial manner to induce biological changes, including 
differentiation, proliferation, and apoptosis [24]. In particular, one ROS, hydrogen 
peroxide (H2O2) acts on the Wnt pathway to stimulate differentiation [25]. Our lab 
recently reported that F9 cells treated with H2O2 show morphological and molecular 
changes similar to that of RA treatment, causing cells to differentiate into PrE [18] 
[Hwang and Kelly, unpublished]. Together the data indicate that ROS are involved in 
crosstalk with the canonical Wnt/β-catenin pathway during ExE differentiation. The 
desire to better understand how this crosstalk augments Wnt signaling forms the basis of 
my thesis. 
 
1.5 Nucleoredoxin and Dishevelled  
Our lab has reported that when F9 cells are treated with RA to induce differentiation 
to PrE, there is an accompanied increase in ROS levels [18]. Furthermore, in the absence 
of RA, F9 cells treated with H2O2 differentiate to PrE. Interestingly, this work also 
highlighted the importance of ROS in the differentiation process as reducing ROS levels 
with antioxidants attenuates differentiation [18]. The mechanism by which ROS acts on 
PrE differentiation is unknown, but evidence from other systems and tissue culture 
models suggests that it may involve Nucleoredoxin (NRX).  
Amino acid sequence similarity indicates that NRX is part of the Thioredoxin (TRX) 
family of redox proteins [26]. TRX is a ubiquitously expressed, evolutionarily conserved 
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protein containing a redox active site, Cysteine-X-X-Cysteine (CXXC). TRX catalyzes 
NADPH dependent reductions of disulfide bridges and functions as a disulfide 
oxidoreductase. Under oxidizing conditions, the thiol functional group on the two 
cysteine residues form a disulfide bridge capable of changing protein function or protein-
protein interactions [27]. In terms of TRX, this disulfide bridge can be reduced by 
thioredoxin reductase and NADPH.  
Evidence from whole-mount in situ hybridizations studies using mouse embryos 
suggests that NRX plays a role in patterning various tissues/regions during 
embryogenesis [26, 28]. Specifically, these in situ patterns show strong NRX expression 
in the limb buds and somites [26]. To date reports detailing the effects of knocking out 
the NRX gene in mouse embryos indicate embryos are smaller than their littermates and 
exhibited craniofacial defects with short frontal regions [29, 30], but nothing is known 
regarding a role of NRX in ExE development. Recently, investigators using NIH3T3 cells 
have reported on the involvement of NRX in canonical Wnt signaling [31]. In this 
investigation, immunoprecipitation followed by mass spectrometry revealed that NRX 
was a major binding partner of Dvl-1.  
In mammals there are three Dvl isoforms: Dvl-1, Dvl-2, and Dvl-3. All isoforms are 
expressed during embryonic development and all show a similar, broad expression 
pattern, which would suggest that they act in a functionally redundant manner [32]. 
Studies in mice show that the individual knockouts of Dvl-1, Dvl-2 or Dvl-3 remain 
viable, but display defects including, but not limited to social, vertebral, and cardiac 
abnormalities. In double knockout studies, however, the absence of Dvl isoforms leads to 
more severe phenotypes including embryonic lethality [33], which would indicate that the 
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remaining isoform is not capable of assuming the role(s) left vacant due to the knockout. 
Incidentally, F9 cells express all three Dvl isoforms, with Dvl-2 constituting 95% of the 
Dvl pool [34]. Therefore, for the purpose of my research, all three Dvl isoforms were 
analysed, but emphasis was placed on Dvl-2. 
The structure of Dvl is conserved amongst the three isoforms and includes three main 
protein binding domains allowing for Dvl to interact with over 60 proteins [35]. The DIX 
domain located at the N-terminus is involved in binding to Axin, a negative regulator of 
Wnt signaling. A central PDZ domain is involved in binding a large number of proteins 
including CK1 and NRX [31]. Lastly, the DEP domain, located at the C-terminus of Dvl, 
is thought to function in G-protein signaling [32].  
 
1.6 Role of Nucleoredoxin in development and rationale 
for further research 
At the onset of my study, the report of an increase in ROS levels following RA 
treatment of F9 cells, and the ability of H2O2 to induce differentiation in an RA-
independent manner [18] left many unanswered questions. Interestingly, recent studies 
demonstrating that redox regulated proteins act on the canonical Wnt pathway [31] point 
to a general phenomenon where ROS play a regulatory role in signal transduction events. 
Furthermore, the observation that the amount of Dvl-1-bound to NRX increases under 
reduced conditions, and decreases when cells are subjected to oxidizing conditions [31], 
would suggest that the redox state of the cell is key in the regulation of these events. In 
this manner, the binding of NRX to Dvl would be expected to augment the negative 
regulation of β-catenin in the Wnt pathway via the destruction complex. In contrast, when 
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cells are exposed to oxidizing conditions, NRX would dissociate from Dvl, allowing it to 
await the Wnt signal and transduce it by destabilizing the β-catenin destruction complex 
[31] (Fig. 1.3). Thus, in this model, NRX serves as an inhibitor in the canonical Wnt 
signaling pathway. This model is supported by evidence from NRX knockout studies, 
where NRX-/- causes perinatal lethality due to dysregulation of Wnt/β-catenin signaling 
[29, 35]. What these knockout studies do not explain is the fact that defects are noted 
later in development and not at earlier stages, where Wnt signaling is known to be 
involved in ExE formation. 
 
 
1.7 Objectives and Hypothesis
 
The objective of this research was to further address the role of NRX and Wnt 
signaling during vertebrate early development with a specific focus on EMTs and ExE 
differentiation. Observations from our lab have shown that in F9 cells, RA induction of 
PrE differentiation causes an upregulation of Wnt6 and activation of the canonical Wnt/β-
catenin pathway. Furthermore, these changes are accompanied by an increase in the 
levels of ROS. Based on these results, together with results from the literature indicating 
that NRX dissociates from Dvl-1 when NIH3T3 cells are treated with H2O2, I 
hypothesize that during RA-induced activation of the canonical Wnt pathway in F9 
cells, the accompanied increase in ROS leads to dissociation of NRX from Dvl, 
thereby augmenting the accumulation of β-catenin in the nucleus that is necessary 
for ExE differentiation. To examine the role of NRX in Wnt signaling and ExE 
differentiaton, the mRNA and protein expression profiles of NRX, Dvl-1, Dvl-2 and Dvl-3 
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in undifferentiated and RA treated F9 cells were determined. Next, co-
immunoprecipitation assay was used to investigate the relationship between NRX and 
Dvl-2 under reducing and oxidizing condition. Finally, sh-NRX was used to knock down 
NRX to assess the effects on ExE formation. 
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Figure 1.3 Increase in ROS causes NRX dissociation from Dvl and enhances canonical 
Wnt signaling. Recent evidence suggests that in the absence of Wnt, NRX binds to Dvl 
and augments the negative regulation of β-catenin via the destruction complex. Following 
an increase in ROS, the thiol functional group on the two cysteine residues of NRX form 
a disulfide bridge, changing the conformation of NRX, thereby allowing it to dissociate 
from Dvl. This release of Dvl inactivates the destruction complex, thus allowing β-
catenin to accumulate and subsequently translocate to the nucleus where it binds to TCF-
LEF to induce Wnt target genes. 
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Chapter 2  
2 Materials and Methods 
 
 
2.1 Cell Culture
 
F9 cells (ATCC) were cultured in Dulbecco’s modified Eagle’s medium (Gibco) 
supplemented with 1 % penicillin-streptomycin (Gibco) and 10 % fetal bovine serum 
(Gibco) and incubated at 37oC and 5 % CO2. Cells were treated with dimethyl sulphoxide 
(DMSO), serving as a control, 10-7 M retinoic acid (RA all-trans; Sigma), or 0.05 mM 
and 0.1 mM H2O2 (EMD). Further analysis of cell differentiation was tested using RA 
plus 0.05 mM dibutyryl cyclic adenosine monophosphate (db-cAMP; Sigma), or H2O2 
and db-cAMP.  
For antioxidant analysis, F9 cells were first treated with 1 mM and 2 mM N-
Acetyl-L-cysteine (NAC; Sigma), or 0.1 mM and 0.5 mM L-Ascorbic acid (Vitamin C; 
Sigma) for 24 h, and then treated with 10-7 M RA.  NAC, Vitamin C and RA were 
replenished every day for 3 days.  
 
2.2 Reverse Transcription PCR and Quantitative Reverse 
Transcription PCR 
Total RNA was collected using the RNeasy kit (Qiagen) and converted into first 
strand cDNA using reverse transcriptase qScript cDNA Supermix (Quanta). RNA was 
isolated following treatment of F9 cells with DMSO, RA (for 1, 2, 3 and 4 days), H2O2 
(for 1, 2, and 3 days) or RA/H2O2 and db-cAMP. Primers were designed to: L14 sense 
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(5’GGGAGAGGTGGCCTCGGACGC) and antisense 
(5’GGCTGGCTTCACTCAAAGGCC) to produce a 300 bp product. L14 is a 
constitutively expressed gene in F9 cells and used as an internal control. NRX sense (5’ 
TCTGCTCACCATTCTGGACA) and antisense (5’ACACGCTGGAAAAGTCCAAG) 
to produce a 200 bp product, Gata6 sense (5’CTCTGCACGCTTTCCCTACT) and 
antisense (5’GTAGGTCGGGTGATGGTGAT) to produce a 200 bp product, FoxA2 
sense (5’ACCTGAGTCCGAGTCTGAGC) and antisense 
(5’CATGGTGATGAGCGAGATGT) to produce a 200 bp product, TM sense 
(5’CCAGGCTCTTACTCCTGTA) and antisense (5’TGGCACTGAAACTCGCAGTT) 
to produce a 200 bp product. Primers were also designed for Dvl-1 sense 
(5’CATCCTCCTTCAGCAGCATCAC) and antisense 
(5’ACTCGTACCATAGCGGGGC) to produce a 450 bp product, Dvl-2 sense 
(5’AGACTCGGATGAGGATGACA) and antisense (5’AAGGCTCCAGTCAGCGCA) 
to produce a 550 bp product, and Dvl-3 sense (5’TGGGGCTGTGGCAGCTGATGG) and 
antisense (5’GAGGCCATGGCTTTTACGATG) to produce a 400 bp product [36].  
Primers were used with first strand cDNA template for reverse transcriptase-
polymerase chain reaction (RT-PCR) using a thermocycler (Eppendorf) and the following 
conditions: NRX – 35 cycles of 30 s at 94oC, 30 s at 55oC, and 30 s at 72oC; Dvl-1 – 40 
cycles of 30 s at 94oC, 30 s at 55oC, and 30 s at 72oC; Dvl-2 – 38 cycles of 30 s at 94oC, 
30 s at 55oC, and 30 s at 72oC; Dvl-3 – 42 cycles of 30 s at 94oC, 30 s at 60oC, and 30 s at 
72oC; Gata6 – 35 cycles of 30 s at 94oC, 30 s at 57oC, and 30 s at 72oC; FoxA2 – 35 
cycles of 30 s at 94°C, 30 s at 58°C, and 30 s at 72°C; TM – 32 cycles of 30 s at 94oC, 30 
s at 57oC, and 30 s at 72oC . PCR products were analyzed on 1 % agarose gels containing 
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ethidium bromide and DNA was visualized using a FluorChem 8900 Gel Doc System 
(Alpha Innotech). All amplicons were sequenced at the Roberts’ Research Institute 
(UWO), to confirm their identity. 
Quantitative reverse transcription-PCR (qRT-PCR) analysis was carried out in 
triplicate using the Rotor Gene 3000 (Corbett). Each reaction contained 1 μL of cDNA, 
500 nM concentrations of each of the primers described above, and a PerfeCTa SYBR 
green PCR Fastmix (Quanta Biosciences). Gene expression analysis was performed using 
the comparative cycle threshold (Ct) method, normalized to L14 expression, and the fold 
changes were calculated relative to control DMSO-treated cells. 
  
 
 2.3 Immunoblot Analysis
 
Protein lysates were collected in 2 % sodium dodecyl sulfate (SDS) buffer 
containing 0.5 M Tris-HCl pH 6.8 (BioShop), 5 % glycerol, 5 % 2-mercaptoethanol 
(BDH), 2 % SDS (BioShop) and 1 % Halt Protease Inhibitor Cocktail (Thermo 
Scientific). Protein concentrations were determined using a Bradford Assay (Bio-Rad).  
Approximately 40 μg of protein were separated on denaturing 10 % polyacrylamide gels 
for 1.5 h at 120 volts. Following electrophoresis, the proteins were electrophoretically 
transferred for 1 h to nitrocellulose membranes (Biotrace; Pall Corp.) using Tris-glycine 
transfer buffer containing 20 % methanol.  The membranes were blocked in Tris buffered 
saline containing 0.1 % Tween 20 (TBS-T) and 5 % skim milk for 1 h at room 
temperature. Membranes were then probed with primary antibody(s) overnight at 4oC 
followed by 3 washes in TBS-T, and then probed with secondary antibody(s) for 2 h at 
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room temperature. Signals were detected using the SuperSignal West Pico 
Chemiluminescent Detection Kit (Pierce) and X-Omat Blue XB-1 Film (Kodak) or 
captured on a Molecular Imager Gel Doc XR System (BioRAD) and imaged using 
Quantity One Software. The primary antibodies were directed against TROMA-1 (1:10; 
55 kDa, Developmental Studies Hybridoma Bank), β-Actin (1:10000; 47 kDa, Santa 
Cruz), NRX (1:250; 55 kDa, Santa Cruz), Dvl-1 (1:250; 85 kDa, Santa Cruz), Dvl-2 
(1:250; 92 kDa, Santa Cruz) and Dvl-3 (1:200; 81 kDa, Santa Cruz) and dissolved in 5 % 
Bovine Serum Albumin (BSA; OmniPur) and TBS-T.  Secondary antibodies including 
HRP-conjugated anti-goat, anti-rat and anti-mouse (1:5000; Pierce) were dissolved in 5 
% skim milk and TBS-T. 
 
 
2.4 Co-Immunoprecipitation
 
Cells grown to approximately 80 % confluency were treated with 1 mM 
dithithreitol (DTT; New England BioLabs) or 1 mM H2O2 for 15 min and protein lysates 
were collected in nonyl phenoxypolyethoxylethanol-40 lysis buffer (NP-40) containing 
50 mM Tris pH 7.2 (BioShop), 100 mM NaCl (BioShop), 0.1 % IGEPAL (Sigma), 10 % 
glycerol, 1 mM ethylenediaminetetraacetic acid (EDTA; Gibco) and 0.1 mM 
phenylmethylsulfonyl fluoride (PMSF; Sigma). Lysates were incubated in NP-40 lysis 
buffer for 10 minutes then passed through a 25-gauge needle 15 times and centrifuged for 
10 min at 4ºC. To immunoprecipitate proteins bound to Dvl-2, protein lysate (2 mg/mL) 
was first pre-cleared using a 20 μL sepharose bead volume (Protein A/G PLUS Agarose 
Immunoprecipitation Reagent; Santa Cruz) for 1 h. Lysates were then treated overnight at 
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4ºC with either 1 μg of anti-Dvl-2 antibody or 1 μg of IgG normal mouse serum (Santa 
Cruz), as a control. Antibody-protein complexes were then immobilized on sepharose 
beads for 2 h at 4ºC. Bound proteins were washed three times with NP-40 lysis buffer, 
eluted from the beads using electrophoresis sample buffer (New England BioLabs), 
resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
and then blotted to nitrocellulose membrane. The membrane was blocked with TBS-T 
and 5 % skim milk for 1 h, and then probed with anti-NRX antibody (1:250) overnight at 
4ºC and then with an HRP-conjugated anti-goat antibody (1:5000) for 2 h. To confirm the 
pull-down of Dvl-2, membranes were stripped and reprobed with anti-Dvl-2 antibody 
(1:250) and HRP-conjugated anti-mouse antibody (1:5000).  
 
  
2.5 sh-NRX construct and Knockdown
 
The following sequence derived from the mouse NRX cDNA was used for the 
knockdown of NRX: (AA)GATCATTGCCAAGTACAAA [31].  Oligonucleotide primers 
designed to amplify the above sequence was used with PCR to clone the NRX sh-RNA 
into the pRS shRNA vector (a generous gift from Dr. Robert Cumming; sh-NRX).  Cells 
were transfected with sh-NRX, or with pRS or CMV-GFP constructs as negative and 
transfection efficiency controls, respectively, using Lipofectamine 2000 and according to 
the manufacturer's protocol (Invitrogen).  Briefly, F9 cells grown to approximately 90 % 
confluency were transfected with 10 uL of Lipofectamine 2000 and 4 ug of each of the 
constructs in 2 mL of Opti-MEM (Invitrogen).  Opti-MEM was replaced with complete 
media 5 h post transfection and cells were cultured for 3 days. For differentiation to PE 
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analysis, Opti-MEM was replaced with complete media plus db-cAMP (0.05 mM).  
mRNA was collected using methods described previously (section 2.2), while protein 
lysates were collected in 2 % SDS lysis buffer. 
  
 
2.6 Microscopy
 
Cells were examined under bright field using a Zeiss Axio Observer A1 inverted 
microscope and images were captured using a QImaging Retiga CCD camera. All images 
were assembled as plates using Adobe Photoshop CS3 and Adobe Illustrator CS3. 
 
  
2.7 Statistical Analysis
 
Densitometric analyses of immunoblots and quantitative reverse transcription PCR 
data were compiled from three independent biological replicate experiments performed 
on separate occasions. Comparisons of data between the control and treated, or 
transfected groups were performed using a one-way ANOVA and Tukey's HSD post-hoc 
tests (SPSS). Data is presented as mean and standard error of the mean. The p values 
were one-sided and considered statistically significant at the 0.05 level. 
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Chapter 3 
3 Results 
 
3.1 RA, H2O2 and db-cAMP induce differentiation of F9 
cells  
 
Previous work in our lab has demonstrated an accompanied increase in ROS levels 
when F9 cells are treated with RA to induce PrE differentiation. Moreover, cells also 
differentiate to PrE when they are treated with H2O2 [18]. To confirm these results, cells 
were treated with RA or H2O2, and then examined for markers of differentiation. RA 
treatments were examined over a 4 day period and compared to DMSO-vehicle treated 
cells. Morphological analysis showed DMSO treatments caused cells to appear compact, 
while treatment with RA showed cells acquiring a more flattened morphology as they 
moved apart from one another. Similarities in morphology to RA-treated cells occurred 
when cells were treated with 0.1 mM H2O2 for 3 consecutive days (Fig. 3.1A).  
Previous work has shown that the addition of db-cAMP to RA-treated F9 cells 
cause them to further differentiate to PE [7]. Although this ability to chemically induce 
F9 cells to form PE is well known, no report had documented whether H2O2 in the 
presence of db-cAMP would have the same outcome. To this end, F9 cells were treated 
with either RA or H2O2, and subsequently with db-cAMP. Results show that the addition 
of H2O2 and db-cAMP caused F9 cells to adopt a similar morphology as RA and db-
cAMP. In each case cells that have moved away from the compact mass displayed 
extended protrusions and appeared more refractile than those exposed to RA or H2O2 
alone (Fig. 3.1A).  
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Figure 3.1 RA and H2O2 induce morphological changes and markers of primitive 
endoderm; with the addition of db-cAMP cells become competent to form parietal 
endoderm. F9 cells were treated with DMSO, RA (10-7 M), H2O2 (0.1 mM), RA and db-
cAMP (0.05 mM) or H2O2 and db-cAMP. (A) F9 cells treated with DMSO grow in 
tightly compact groups (top), whereas those treated with H2O2 show a flattened, more 
elongated morphology, similar to that of RA-treated cells (middle). H2O2-treated cells 
exposed to db-cAMP become refractile, and show extended protrusions reminiscent of 
RA and db-cAMP (bottom). (B) Immunoblot analysis for TROMA-1 shows expression 
induced by RA treatments, with the highest levels present on day 4. (C) Immunoblot 
analysis shows expression of TROMA-1 increased by H2O2 treatment, with the highest 
levels present on day 3. (D) RT-PCR analysis shows increased TM in cells treated with 
RA and db-cAMP and in those treated with H2O2 and db-cAMP. Data represents 3 
independent experiments. Scale bars = 20 μm.   
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Immunoblot analysis, using the TROMA-1 antibody to detect the characteristic 
assembly of cytokeratin A intermediate filaments that is seen in PrE, was used to confirm 
the morphological changes that resulted from RA and H2O2 treatments. As expected, 
TROMA-1 signals were not seen in DMSO treated control cells, but were present after 
RA treatment, with the highest level after 4 days (Fig 3.1B). Likewise, a similar pattern 
of TROMA-1 staining was seen in H2O2 treated cells. DMSO had no effect on TROMA-1 
levels, while treatment with H2O2 for 3 days caused an increase (Fig. 3.1C). These 
morphological and molecular results confirmed that F9 cells treated with either RA or 
H2O2 had differentiated into PrE [18].  
Since H2O2 was able to take the place of RA and direct cells into the PrE lineage, 
the next question was to test whether these H2O2-induced cells were competent to further 
differentiate into PE. RT-PCR was used to detect Thrombomodulin (TM), a marker of PE 
differentiation. As expected, TM was not detected in DMSO, RA, or H2O2 treatments, but 
with the addition of db-cAMP the expression of TM increased (Fig. 3.1D). Together, 
these results indicated that H2O2/db-cAMP treatment was sufficient to induce F9 cells to 
form PE.    
 
3.2 Antioxidants attenuate RA-induced differentiation  
Studies from the Kelly lab have shown that increasing ROS levels in F9 cells is 
sufficient to induce them to differentiate into PrE, while blocking ROS production 
through addition of antioxidants inhibits differentiation [18]. To confirm these studies, F9 
cells were treated with DMSO, RA or increasing concentrations (1 mM and 2 mM) of N-
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Acetyl Cysteine (NAC) supplemented with RA. To determine if the block to 
differentiation was NAC-specific, F9 cells were also treated with various concentrations 
(0.1 mM and 0.5 mM) of the antioxidant ascorbic acid, the reduced form of Vitamin C, 
and then exposed to RA.  
Immunoblot analysis showed no TROMA-1 signal when cells were treated with 
DMSO alone, but signals were seen in RA-treated cells (Fig. 3.2A). Compared to RA 
alone, cells treated with NAC or Vitamin C showed weaker TROMA-1 signals (Fig. 
3.2A). Densitometry analysis comparing TROMA-1 levels relative to the β-actin loading 
control was performed. Results indicate that in comparison to RA, TROMA-1 levels 
decreased significantly in cells treated with 1 mM and 2 mM NAC and in those treated 
with 0.5 mM Vitamin C (Fig. 3.2B). While a concentration of 0.1 mM Vitamin C showed 
a decrease in TROMA-1, these levels were not found to be significant. As expected, cells 
treated with DMSO had TROMA-1 levels that were significantly lower than the RA, 
positive control. Together, these results indicate that exposure to antioxidants inhibits 
RA-induced differentiation of F9 cells into PrE, suggesting that ROS are necessary and 
sufficient for this to process to occur.  
 
3.3 Dvl-1, Dvl-2 and Dvl-3 mRNA expression profiles 
remain constant after RA treatment 
In the presence of Wnt, Dvl is recruited to the plasma membrane and acts to 
disassemble a destruction complex that otherwise would target β-catenin for proteasomal 
degradation. Since RA is known to affect the expression of many genes [11], including in 
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Figure 3.2 Antioxidants NAC and Vitamin C attenuate RA-induced differentiation in F9 
cells. F9 cells were treated with NAC (1 mM and 2 mM) or Vitamin C (0.1 mM and 0.5 
mM) for one day, and then treated with RA (10-7 M). Cells treated with DMSO or RA 
(10-7 M) served as a control. (A) Immunoblot analysis for TROMA-1 showing levels of 
endo-A cytokeratin in cells treated with RA, but not in the DMSO control. These levels 
decreased when cells were treated with NAC and then exposed to RA, or when treated 
with Vitamin C and then RA. (B) Densitometry analysis show that there was a significant 
decrease in the TROMA-1-positive signals in cells treated with NAC (1 mM and 2 mM) 
or Vitamin C (0.5 mM) and RA, compared to those treated with RA alone. TROMA-1 
was not significantly different in cells treated with Vitamin C (0.1 mM) plus RA, 
compared to those treated with RA alone. Densitometry was calculated by comparing the 
TROMA-1/β-actin ratio of each treatment to the same ratio in the RA control treatment. 
Asterisks denote significant difference (p≤0.05). Data represents the mean and standard 
error of three independent experiments. 
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Wnt6 [16], the possibility exists that other members of the canonical Wnt signaling 
pathway, and in particular Dvl, may be regulated at either the mRNA or protein level in 
F9 cells treated with RA. To address this, the relative mRNA levels of all three Dvl 
isoforms were analysed to determine if the Dvl genes are RA-responsive.  
The mRNA expression profile of Dvl-1, Dvl-2 and Dvl-3 was determined in cells 
treated with DMSO or RA for 1 to 4 days. RT-PCR was employed and amplicons 
confirmed that all three Dvl isoforms are present in F9 cells; however, relative levels 
appeared similar between the RA-treated and DMSO control cells (Fig. 3.3A-C). Since 
these levels appeared constant, it was necessary to use qRT-PCR to determine if subtle 
differences in expression exist. The expression levels of Dvl-1, 2 and 3, normalized to 
L14, was determined in RA-treated cells and compared to the vehicle control. Results 
confirmed there was no significant change in the expression levels of Dvl-1, 2 or 3 in RA-
treated cells compared to DMSO (Fig. 3.3D-F). To confirm these results, these mRNA 
expression levels were compared to that of a known RA-responsive gene, Gata6 [12]. 
qRT-PCR results showed that Gata6 expression increased at 1 day post-RA treatment and 
continued to increase significantly through day 4 (Fig. 3.3G). In light of the Gata6 
expression, it would appear that Dvl-1, Dvl-2 and Dvl-3 are not RA-responsive genes.  
 
3.4 Dvl-1, Dvl-2 and Dvl-3 protein expression profiles 
remain constant after RA treatment 
Since there were no obvious changes in the levels of Dvl-1, 2 or 3 mRNA in response 
to RA, I decided to use immunoblot analysis to investigate Dvl-1, 2 and 3 protein levels  
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Figure 3.3 Dvl-1, Dvl-2 and Dvl-3 mRNA levels are not affected by RA treatment. F9 
cells were treated with DMSO or RA (10-7 M) for 1 to 4 days and total RNA was 
collected, reverse transcribed into first strand cDNA, and used as template for PCR 
analysis with primers designed to Dvl-1, Dvl-2 and Dvl-3. (A-C) Three separate RT-PCR 
experiments show all three Dvl genes are expressed in both DMSO and RA-treated cells. 
(D-F) qRT-PCR analysis shows that there was no significant difference in the transcript 
level of any Dvl. (G) qRT-PCR, with primers designed to Gata6, an RA-responsive gene, 
show that there is a significant increase in Gata6 expression in cells following treatment 
with RA. For qRT-PCR analysis, the expression levels of Dvl-1, -2, -3 and Gata6 were 
normalized to L14 and compared to the vehicle control. Asterisks denote significant 
difference (p≤0.05). Data represents the mean and standard error of three independent 
experiments. 
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under the same conditions. Antibodies against each specific Dvl were used on blots 
containing proteins isolated from DMSO or RA-treated cells. A β-actin antibody was 
used to ensure equal loading between samples. Results show that Dvl-1, 2 and 3 were 
present in both vehicle-treated and RA-treated cells (Fig. 3.4A-C). Furthermore, 
densitometry analysis confirmed that there were no significant changes in the levels of 
each Dvl isoform in either DMSO or RA-treated cells (Fig. 3.4D-F).  
 
3.5 NRX mRNA expression profile remains constant after 
RA treatment 
Since Dvl was not RA-responsive as RA had no effect on the steady state levels of 
any of the three Dvl isoforms, the focus turned to NRX, a protein known to interact with 
Dvl [31] and one that is redox sensitive [26]. These results were particularly intriguing 
given the effects of treating F9 cells with H2O2 (described above in section 3.1). First, to 
determine if the expression of NRX changed in response to RA, cells were treated with 
RA for 1 to 4 days and total RNA was collected. The RNA was then reverse transcribed 
into first strand cDNA and used as a template for PCR with NRX specific primers.  
Results show that NRX was present in DMSO-treated (undifferentiated) F9 cells (Fig. 
3.5A).  Furthermore, the levels of NRX appeared to remain constant following RA 
treatment. qRT-PCR was used to determine if there were any subtle changes in NRX 
expression. Results, normalized to the vehicle control and compared to RA treatments at 
days 1 to 4, show that there were no significant changes in NRX expression between 
DMSO and RA-treated cells (Fig. 3.5B).   
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Figure 3.4 Dvl-1, Dvl-2 and Dvl-3 protein levels are not affected by RA treatment. F9 
cells were treated with DMSO or RA (10-7 M) for 1 to 4 days and protein lysates were 
collected and used for immunoblot analysis with antibodies against Dvl-1, Dvl-2 and 
Dvl-3. (A-C) Immunoblot showing Dvl-1, Dvl-2, and Dvl-3 in DMSO and RA-treated F9 
cells. Note that the relative levels of Dvl-1, Dvl-2 and Dvl-3 did not change following 
treatment. (D-F) Densitometry analysis confirms that there were no significant changes in 
Dvl-1, Dvl-2 or Dvl-3 protein levels following either DMSO or RA treatment. 
Densitometry was calculated by comparing the Dvl-1, -2, -3/β-actin ratio of each 
treatment to the same ratio in the vehicle control treatment. Asterisks denote significant 
difference (p≤0.05). Data represents the mean and standard error of three independent 
experiments. 
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Figure 3.5 NRX mRNA levels are not affected by RA treatment. F9 cells were treated with 
DMSO or RA (10-7 M) for 1 to 4 days. Total RNA was collected, reverse transcribed into 
first strand cDNA, and used as template for PCR analysis with primers designed to NRX. 
(A) RT-PCR results show that the NRX mRNA transcript is present after treatment with 
DMSO or RA. (B) qRT-PCR data confirmed that there were no significant differences in 
mRNA transcript levels of NRX between treatments. For qRT-PCR analysis, the 
expression level of NRX was normalized to L14 and compared to the vehicle control. 
Asterisks denote significant difference (p≤0.05). Data represents the mean and standard 
error of three independent experiments. 
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Unlike Gata6 (Fig. 3.3G), these results strongly suggest that NRX is not RA-
responsive.  
 
3.6 NRX protein expression profile remains constant after 
RA treatment 
To complete my analysis of NRX it was necessary to determine if RA affected the 
steady state levels of the protein. Total protein lysates from cells treated with DMSO or 
RA for 1 to 4 days were separated, transferred to membranes and then probed with either 
an NRX antibody or an antibody for β-actin, the latter protein serving as a loading 
control. Results show NRX bands, of the expected molecular mass, in DMSO and RA-
treated cells (Fig. 3.6A). Furthermore, densitometry analysis showed no significant 
change in NRX protein levels between treatments (Fig. 3.6B). These results, like those 
for Dvl, show that NRX is expressed in undifferentiated F9 cells as well as in PrE cells 
induced by RA. Thus, if NRX can regulate Dvl and keep F9 cells in an undifferentiated 
state when Wnt ligands are absent, then the apparent inability of RA to alter the steady-
state levels of either of these proteins would suggest that some other post-translational 
mechanism of regulation must be in effect. 
 
3.7 Interaction between NRX and Dvl-2 is redox regulated  
Given that F9 cells treated with RA demonstrate increased Wnt6 expression and 
differentiate into PrE and that this increase is accompanied by a concomitant increase in  
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Figure 3.6 NRX protein levels are not RA responsive. F9 cells were treated with DMSO 
or RA (10-7 M) for 1 to 4 days and protein lysates were collected and used for 
immunoblot analysis. (A) Immunoblot showing relative NRX levels after cells were 
treated with DMSO or RA. NRX protein levels were not affected by RA treatment. (B) 
Densitometry results show no significant change in NRX protein levels in DMSO or RA 
treated cells. Densitometry was calculated by comparing the NRX/β-actin ratio of each 
treatment to the same ratio in the vehicle control treatment. Asterisks denote significant 
difference (p≤0.05). Data is representative as the mean and standard error of three 
independent experiments. 
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the levels of ROS, and treating F9 cells with H2O2 also induces differentiation  [18], it is 
tempting to speculate that the redox state of the cell impacts on canonical Wnt signaling 
required for differentiation. The studies with NIH3T3 cells, showing that the interaction 
between NRX and Dvl-1 is redox regulated, also lends support to this model, implicating 
ROS signaling crosstalk with the Wnt pathway. Since NRX and Dvl are not responsive to 
RA in F9 cells, the possibility therefore exists that the increase in ROS following RA 
treatment plays a post-translational role in regulating the interaction between NRX and 
Dvl. If this is the case, then the ROS might be expected to cause disulfide bridge 
formation in the CXXC site of NRX, altering its conformation and affecting its ability to 
interact with Dvl. If my hypothesis is correct, then I expect to find NRX bound to Dvl in 
untreated F9 cells. Likewise, I predict that NRX would dissociate from Dvl when F9 cells 
are exposed to increasing levels of ROS. As noted above, Dvl-2 is the most abundant of 
the Dvl isoforms in F9 cells. I thus chose to further examine the relationship between 
NRX and Dvl-2. 
To test my hypothesis, F9 cells were cultured and treated with H2O2, DTT (a strong 
reducing agent) or left untreated. Whole cell lysates were isolated and 
immunoprecipitated using an anti-Dvl-2 antibody to test the interaction between Dvl-2 
and NRX. Normal mouse IgG was used as a negative control to assess for non-specific 
binding (Fig. 3.7A Lane 1). Following immunoprecipitation, immunoblot analysis 
revealed that in untreated cells, NRX binds to Dvl-2 (Lane 2). This interaction between 
NRX and Dvl-2 increased under strong reducing conditions (Lane 3), while under 
oxidizing conditions it appeared that the level of NRX bound to Dvl-2 decreased (Lane 
4). Densitometry analysis was then used to assess the relative amounts of NRX-bound to 
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Figure 3.7 The interaction between NRX and Dvl-2 in F9 cells is redox-dependent. Cells 
were either untreated, or treated with DTT (1 mM) or H2O2 (1 mM) for 15 min and 
protein lysates were collected. Protein complexes were immunoprecipitated with an anti-
Dvl-2 antibody or with an IgG Normal Mouse as a control. (A) Immunoblot results show 
that compared to controls, NRX levels pulled down with Dvl-2 decrease when cells were 
treated with H2O2.  In converse, cells treated with DTT show that more NRX was pulled 
down in the Dvl-2 complex. (B) Densitometry analysis confirmed that NRX protein 
levels were significantly less in H2O2-treated cells compared to those treated with DTT. 
Densitometry was calculated by comparing the NRX/Dvl-2 ratio of DTT and H2O2 
treatments to the same ratio in the untreated control. Asterisks denote significant 
difference (p≤0.05). Data is representative as the mean and standard error of three 
independent experiments. 
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Dvl-2 under the different treatment regimes (Fig. 3.7B). The data represent NRX bound 
to immunoprecipitated Dvl-2, and normalized to the levels of Dvl-2 pulled down. There 
was a significant difference in the amount of NRX bound to Dvl-2 when cells were 
subjected to DTT compared to H2O2 treatment (p=0.03). While there were differences in 
the amount of NRX bound to Dvl-2 in DTT and H2O2, compared to that in untreated cells, 
these differences were not significant (p=0.06 and p=0.80 respectively). These results 
provide evidence that NRX interacts with Dvl-2 in F9 cells, and furthermore that this 
relationship is redox dependent.  
 
3.8 NRX knockdown differentiates F9 cells to PrE
 NRX inhibits Dvl in the absence of Wnt, causing degradation of β-catenin and 
thus preventing the interaction between β-catenin and TCF-LEF [31]. In F9 cells, NRX is 
bound to Dvl-2 and the increase in ROS, following RA-induced Wnt activation, may 
affect the redox interaction between NRX and Dvl-2. That said, if ROS induce a 
conformational change in NRX this would free up a pool of Dvl, thereby priming it to be 
recruited to the plasma membrane if and when a Wnt ligand presents itself to a Fzd 
receptor. On the other hand, freeing up Dvl may be sufficient to activate the pathway in 
the absence of Wnt, as evident from studies showing the overexpression of Dvl alone 
upsets the stoichiometry of the Wnt pathway leading to activation [37]. In any event, the 
end result would be the accumulation of β-catenin, its translocation into the nucleus and 
its subsequent interaction with TCF-LEF to impart changes in gene expression necessary 
for PrE differentiation. If this premise is true, then knocking down NRX should release 
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the inhibition of Dvl and, in the absence of RA, free up enough Dvl to activate β-catenin-
dependent gene expression needed for cells to differentiate into PrE. 
To address my hypothesis, NRX was knocked down by transfecting F9 cells with a 
shRNA that specifically targets NRX. Changes in morphology were then evaluated using 
phase contrast microscopy. F9 cells were also transfected with the pRS empty vector 
plasmid (pRS-EV) as a control. Morphologically, cells transfected with pRS-EV and 
those treated with DMSO are similar and show cells growing in compact bodies, 
reminiscent of undifferentiated cells (Fig. 3.8A). Cells transfected with sh-NRX were 
elongated and flattened and showed changes in morphology including protrusions that 
differed from DMSO or pRS-EV-transfected cells. Interestingly, the sh-NRX morphology 
appeared similar to that caused by RA, suggesting the NRX knockdown was able to 
differentiate cells into PrE (Fig. 3.8A). 
To test whether or not the NRX knockdown had induced cells to differentiate into 
PrE, protein lysates were collected for cells treated with DMSO or RA or transfected with 
pRS-EV or sh-NRX. Immunoblot analysis and the TROMA-1 antibody were used to 
detect the expression of cytokeratin intermediate filaments, a marker of PrE. An anti-
NRX antibody was used to confirm the knockdown and β-actin was used to ensure equal 
amounts of protein were assayed between the different regimens. As expected, TROMA-
1 levels appeared higher in RA treated cells compared to those treated with DMSO (Fig. 
3.8B). TROMA-1 levels also appeared higher in cells transfected with sh-NRX compared 
to those transfected with pRS-EV (Fig. 3.8B). Densitometry data confirmed these results,  
 
 
 
46 
 
Figure 3.8 NRX knockdown increased endo-A cytokeratin levels indicative of 
extraembryonic endoderm differentiation. F9 cells transfected with sh-NRX or pRS-EV or 
treated with DMSO or RA (10-7 M), as controls, were examined morphologically or 
processed for immunoblot analysis using the TROMA-1 antibody to detect endo-A 
intermediate filaments. (A) F9 cells transfected with pRS-EV are morphologically similar 
to cells treated with DMSO, appearing in tightly compact groups reminiscent of 
undifferentiated cells. In contrast, F9 cells transfected with sh-NRX show a flattened, 
more elongated morphology, comparable to RA-treated differentiated primitive endoderm 
cells. (B) Immunoblot analysis with the TROMA-1 antibody indicates that endo-A 
intermediate filaments were present in cells transfected with sh-NRX, but not in cells 
transfected with the empty vector. This increase was seen in the RA-treated positive 
controls, but not in the DMSO negative control. Antibodies to NRX confirmed the 
efficiency of the NRX knockdown, while antibodies to β-actin was to ensure equal 
loading between samples. (C) Densitometry analysis confirmed that there was a 
significant increase in TROMA-1 positive signal when cells were transfected with sh-
NRX or treated with RA compared to those transfected with pRS-EV or treated with 
DMSO, respectively. Densitometry was calculated by comparing the TROMA-1/β-actin 
ratio of RA and sh-NRX to the same ratio in the vehicle and pRS-EV control respectively. 
Asterisks denote significant difference (p≤0.05). Data is representative as the mean and 
standard error of three independent experiments. Scale bars = 20 μm. 
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and showed there was a significant increase in TROMA-1 levels in RA-treated cells 
compared to those seen in DMSO treatments (Fig 3.8C). These levels were comparable to 
the significant increase seen in TROMA-1 levels resulting from the NRX knockdown 
(Fig. 3.8C). Thus, in the absence of RA, NRX knockdown in F9 cells is sufficient to 
induce PrE.  
 
3.9 NRX knockdown plus db-cAMP differentiates F9 cells 
to PE 
Since knocking down NRX caused cells to differentiate into PrE, the question 
remained as to whether or not F9 cells deficient in NRX were competent, under the right 
conditions, to differentiate into PE. To test this notion, sh-NRX transfected cells were 
treated with db-cAMP. As a control, cells were transfected with pRS-EV and treated with 
db-cAMP. Morphologically, cells transfected with pRS-EV and treated with db-cAMP 
were indistinguishable from those treated with DMSO. Both treatments showed cells 
growing in compact bodies, reminiscent of undifferentiated cells (Fig 3.9A). In contrast, 
cells transfected with sh-NRX and treated with db-cAMP were morphologically similar to 
those treated with RA and db-cAMP. sh-NRX-transfected and db-cAMP-treated cells 
exhibited the hallmark features of PE cells that had been induced by RA and db-cAMP, 
including extended cell protrusions and a refractile appearance (Fig. 3.9A).  
Next, mRNA was isolated and converted into cDNA for a qRT-PCR analysis to 
confirm that the morphological changes resulting from the NRX knockdown were 
associated with decreased levels of NRX expression. qRT-PCR results show cells  
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Figure 3.9 F9 cells transfected with sh-NRX and treated with db-cAMP form parietal 
endoderm. Total RNA from F9 cells transfected with  pRS-EV or  sh-NRX, or transfected 
with pRS-EV or sh-NRX and then treated with db-cAMP was isolated, reverse transcribed 
into first strand cDNA, and used as template for PCR analysis with primers designed to 
NRX, TM, and L14 (control). RNA was also collected from cells treated with DMSO, RA 
(10-7 M), or RA and db-cAMP (0.05 mM). (A) F9 cells transfected with pRS-EV and 
treated with db-cAMP grow in tightly compact groups, similar to DMSO-treated cells. F9 
cells transfected with sh-NRX and then treated with db-cAMP are morphologically 
different from controls, having increased cell protrusions and a refractile appearance.  
This morphology is reminiscent of cells treated with RA and db-cAMP. (B) qRT-PCR 
analysis for NRX confirms that there was a significant decrease in the level of NRX in 
cells transfected with sh-NRX and in cells transfected with sh-NRX and treated with db-
cAMP. (C) qRT-PCR results show NRX levels at the exponential (cycle 25) and the 
plateau (cycle 40) phases. Note that during the exponential phase a NRX amplicon is not 
seen in cells transfected with sh-NRX or in those transfected with sh-NRX and then 
treated with db-cAMP.  An amplicon, however, was seen at the plateau phase. (D) qRT-
PCR indicates that compared to the empty vector control, there was a significant increase 
in TM in cells transfected with sh-NRX and treated with db-cAMP. The same is true for 
RA and db-cAMP-treated cells compared to the DMSO control. (E) The TM signal at the 
exponential (cycle 29) phase from cells transfected with sh-NRX and then treated with db-
cAMP is similar to the signal seen from cells treated with RA and db-cAMP. The 
increase in TM expression is seen at the plateau phase under all treatment regimes. For 
qRT-PCR analysis, the expression level of NRX and TM was normalized to L14 and 
 
 
50 
 
compared to the vehicle or pRS-EV control. Asterisks denote significant difference 
(p≤0.05). Data is representative as the mean and standard error of three independent 
experiments. Scale bars = 20 μm. 
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transfected with sh-NRX had a significant decrease in NRX levels compared to cells 
transfected with the pRS-EV (Fig. 3.9B). To account for the fact that the knockdown was 
not 100% efficient, qRT-PCR samples were run in duplicate, stopping one set at the cycle 
threshold, the number of cycles at which the dsDNA fluoresces. The second set was run 
until completion, the full 40 cycles. Samples from both groups were electrophoresed on 
agarose gels and images collected.  These results show that after 25 cycles, the cycle 
threshold, NRX amplicons were not evident in cells transfected with sh-NRX or in those 
transfected sh-NRX and treated with db-cAMP; however, transcript levels of NRX after 40 
cycles, the endpoint, show similar NRX transcript levels in all treatments (Fig. 3.9C). 
Therefore, visualising NRX at its cycle threshold, using electrophoresis and qRT-PCR 
data, indicates the efficiency of the knockdown. 
The efficiency of the NRX knockdown was confirmed, and the morphological 
changes seen due to the knockdown suggested cells had differentiated to PE. To confirm 
the latter, qRT-PCR was used with primers designed against the PE marker TM. Relative 
to their respective controls, there was a significant increase in the TM expression in cells 
treated with RA and db-cAMP and in cells transfected with sh-NRX and then 
subsequently treated with db-cAMP (Fig. 3.9D). Samples were assayed at the cycle 
threshold (cycle 29), and at the 40 cycle endpoint (Fig. 3.9E). After 29 cycles, treatments 
with DMSO or RA alone had no effect on TM expression. In contrast, TM amplicons 
were seen in the RA and db-cAMP positive control. TM amplicons were not detected in 
cells transfected with pRS-EV alone, or pRS-EV and then treated with db-cAMP. Finally, 
transfecting cells with sh-NRX had no affect on up-regulating the TM gene, but adding 
db-cAMP following transfection resulted in increased TM expression. That transcript 
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levels of TM after 40 cycles appear similar in all treatments highlights the importance of 
validating qRT-PCR data at the cycle threshold of the gene of interest.   
Together, these results confirm that the knockdown of NRX alone is not sufficient 
to induce F9 cells to differentiate as PE. Likewise, transfecting cells with the pRS-EV 
construct and them treating with db-cAMP does not induce cells to PE. Rather, in a 
manner that mimics the induction of PE by RA and db-cAMP, the NRX knockdown is 
sufficient to induce cells to differentiate as PrE that is competent to differentiate into PE 
when challenged with db-cAMP. 
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Chapter 4 
4 Discussion 
 
Wnt signaling plays numerous roles in vertebrate and invertebrate development and 
if the molecular changes seen in the in vitro F9 model are bona fide and directly 
recapitulate those in vivo, then we can infer that the redox regulation of the Wnt signaling 
pathway is responsible for specifying a select group of ICM cells to differentiate as PrE. 
In addition to canonical Wnt/β-catenin signaling, two other pathways involving Wnt 
include the planar cell polarity (PCP) and the Wnt/Ca2+ pathways. The PCP pathway is 
important in gastrulation as it mediates changes in the cytoskeleton affecting cell 
morphology. For PCP signaling, Wnt works through Fzd and Dvl to act on the Rho-Rac-
JNK pathway, independent of β-catenin [12]. PCP signaling also plays a role in the 
differentiation of F9 cells into PrE [38], but investigating this pathway in addition to 
canonical Wnt signaling was beyond the scope of my thesis.  Likewise, the third and least 
understood Wnt pathway involving Wnt/Ca2+ was not investigated, and to date only one 
paper has been reported to indirectly implicate the involvement of this pathway in F9 cell 
differentiation [39]. Nevertheless, the fact that the Wnt/Ca2+ pathway signals through 
Fzd, G-proteins, calcium/calmodulin-dependent kinase II and protein kinase C to trigger 
downstream targets for cellular polarity and adhesion affecting body axis specification 
during embryogenesis [40], it may be imprudent to dismiss it in having a role earlier in 
mouse development. Given the three known Wnt pathways, the focus of my research was 
on redox regulation pertaining only to Wnt/β-catenin signaling. 
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A growing body of evidence, including some provided by this work, indicates that 
Wnt/β-catenin signaling is redox regulated and that ROS play a significant role in these 
early events. My study used the F9 teratocarcinoma cell line, which differentiates into 
PrE upon the addition of RA, and PE following treatment with RA and db-cAMP. The 
addition of RA is accompanied by increased ROS levels, which are necessary to facilitate 
the differentiation to PrE [18]. Furthermore, when F9 cells are treated with RA, data 
indicates that the accompanied increase in ROS signaling is necessary to regulate 
components of the Wnt pathway, in particular NRX and Dvl.  
Our working model proposes that in the absence of Wnt, NRX binds Dvl, thereby 
preventing the latter from destabilizing the β-catenin destruction complex. RA causes 
changes in gene expression, including the upregulation of Wnt6, and an increase in ROS 
which results in the dissociation of Dvl from NRX. Dvl is now primed and is recruited to 
the plasma membrane following binding of the Wnt ligand to its Fzd receptor and LRP-
5/6 co-receptor. The subsequent increase in cytoplasmic β-catenin, resulting from the 
disassembly of its GSK-3β, Axin and APC destruction complex, leads to its translocation 
into the nucleus where together with TCF-LEF, it can impart changes in gene expression 
necessary for PrE differentiation [16, 18]. This model is of course in its simplest form and 
one might question why the cell needs the negative regulation of NRX on Dvl when the 
Wnt ligand is absent. Although there are many plausible explanations, the one we favour 
involves a failsafe mechanism, where this negative regulation prevents aberrant activation 
of the Wnt pathway in the absence of the Wnt ligand. This may also explain why the 
pathway can be activated by overexpressing Dvl [31]. 
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4.1  Increase in ROS is necessary for ExE differentiation 
 
RA is a morphogen that acts via nuclear receptors to exert its effects on F9 cells to 
induce PrE [41]. Treatment of F9 cells with RA and db-cAMP further differentiates cells 
from PrE to PE. This differentiation of F9 cells to PrE and PE is accompanied by reduced 
cell proliferation, morphological changes, and transcriptional activation of several genes 
including cytokeratin endo-A and tissue plasminogen activator [42]. Recently, we found 
that this RA-induced differentiation to PrE in F9 cells is accompanied by an increase in 
the levels of ROS. Furthermore, it was shown that RA signaling and the subsequent 
increase in the levels of ROS converge on the canonical Wnt-β-catenin pathway, which 
incidentally is required to induce PrE [18]. My study confirmed that RA and ROS 
converge in F9 cells to induce PrE by detection of cytokeratin endo-A in RA and H2O2 
treated cells. Likewise, my results corroborate those showing that TM is expressed when 
RA-treated F9 cells are exposed to compounds that elevate intracellular cyclic AMP 
levels indicating differentiation to PE [14]. Two very significant findings derived from 
my study pertained to PE, and its ability to form in the absence of RA, when F9 cells are 
either treated with H2O2 and db-cAMP or when NRX depleted F9 cells are treated with 
db-cAMP. These studies highlight the importance of redox signaling in the regulation of 
cellular processes associated with differentiation. 
The regulation of redox signaling in cells is imperative as high ROS levels may 
lead to cellular damage [21]. The importance of redox signaling with respect to 
differentiation has recently attracted much attention. For instance, Yanes et al. (2010) 
showed that the amounts of oxidative and reducing agents present in embryonic stem 
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cells are inversely related and important in mediating embryonic cell fate [43]. 
Furthermore, my study has revealed that exposure to reducing agents like ascorbic acid 
(Vitamin C) or NAC, significantly reduces the ability of F9 cells to differentiate in the 
presence of RA, and this is consistent with the notion that signaling pathways involved in 
differentiation are redox regulated. That low levels of Vitamin C (0.1 mM) were not 
sufficient to significantly reduce the ability of F9 cells to differentiate in the presence of 
RA may be explained by the fact that these antioxidant levels along with the increase of 
ROS following RA-induction were not high enough to upset the redox regulation, and 
while differentiation is hindered, it is not significantly affected. Higher concentrations of 
Vitamin C (0.5 mM) and NAC (1 mM and 2 mM), however, were sufficient to overcome 
the increase in ROS levels following RA treatment and therefore were able to retard 
differentiation. While intracellular ROS levels were unaccounted for in this study, the 
idea is consistent with previous reports indicating that the intracellular oxidation state 
regulates cell differentiation [43]. 
 
4.2  Dvl and NRX are not RA responsive in F9 cells
 
Treatment of F9 cells with RA, and subsequent increase in ROS levels activates 
Wnt signaling, specifically Wnt6 in F9 cells, causing differentiation to PrE [16]. This 
increase in Wnt6 is caused by upregulation of the RA responsive genes, Gata6 and 
FoxA2; Gata6 is a direct target gene of RA signaling and FoxA2 a target gene of Gata6 
[12]. Wnt6 in F9 cells is necessary for PrE differentiation as the binding of Wnt to its 
receptors cause Dvl to be recruited to the plasma membrane. Here, Dvl acts to inhibit the 
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destruction complex allowing β-catenin to accumulate and bind to TCF-LEF in the 
nucleus to activate genes necessary for PrE differentiation. Since RA causes increased 
levels of Gata6 and FoxA2, which in turn activate Wnt signaling, and since Dvl is an 
important regulator of the Wnt signaling pathway, I examined the possibility of Dvl 
regulation by RA induction. Studies by Lee et al. (2008) on Dvl in F9 cells indicate all 
three isoforms are present and show great importance in Wnt signaling as the loss of Dvl 
decreases the canonical response to Wnt by impacting TCF-LEF response [34]. My study 
confirms the presence of all three Dvl isoforms in F9 cells, and demonstrated that upon 
RA treatment the relative levels of Dvl remain constant in comparison to vehicle treated 
cells. Even though Dvl is not RA responsive, the presence of Dvl-1, Dvl-2, and Dvl-3 in 
both undifferentiated and differentiated cells indicates its importance to F9 cells.  
 Interestingly, Funato et al. (2006) reported that Dvl binds to NRX in the Wnt/β-
catenin pathway. Since NRX is a binding partner of Dvl, it was thought that if Dvl is not 
regulated by RA then a possible candidate is NRX. My study is the first to look at the 
role of NRX in F9 cells and its affect on differentiation to ExE. While I found that NRX 
is present in F9 cells, the expression of NRX remained constant following RA treatment 
compared to vehicle treated cells. While neither NRX nor Dvl show response to RA 
treatment, their steady-state levels would indicate that they are regulated by other post-
translational mechanisms. 
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4.3 Redox regulated interaction between NRX and Dvl-2
 
 
The results of this study clearly show that the levels of NRX and Dvl mRNA or 
protein in F9 cells were not affected by RA.  However, their ability to interact under 
oxidizing and reducing conditions, which in the case of the former would mimic the ROS 
burst that accompanies differentiation, was examined in detail. Previous reports have 
shown that NRX is redox-regulated as it contains an amino acid sequence with a redox 
active site, CXXC. Under oxidizing conditions, the thiol functional group on the two 
cysteine residues, in the CXXC motif, form a disulfide bridge capable of changing 
protein function or protein-protein interactions [27, 31]. Given this evidence, it seemed 
likely that ROS would affect the redox active site on NRX in F9 cells, thereby altering its 
conformation and ability to interact with other proteins [18]. Interestingly, 
immunoprecipitation studies and mass spectrometry of NIH3T3 murine fibroblast cells 
have been used to identify NRX as a Dvl-1 binding protein [31]. Since NRX contains a 
redox active site, the authors of this study tested the effects of oxidizing and reducing 
conditions on Dvl-1-NRX binding. Their data clearly show that NRX-bound Dvl-1 
increases under reducing conditions, and decreases under oxidizing conditions [31], 
thereby reinforcing the idea that NRX is a redox sensitive protein.   
The interaction between NRX and Dvl was also shown for F9 cells in my study. 
Here, the relationship between NRX and Dvl-2 was observed using co-
immunoprecipitation analysis. Using this technique I was able to show that the amount of 
NRX-bound to Dvl-2 increased under reducing conditions; conversely the amount of 
NRX-bound to Dvl-2 decreased under oxidizing conditions. 
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Given these results it seems logical to predict that the burst of ROS that occurs in 
F9 cells treated with RA [18] would impact on the ability of NRX to bind Dvl-2, freeing 
up the latter to transduce the Wnt signal when the ligand is present.   
 
4.4 NRX inhibits Wnt signaling induced ExE differentiation
 
Given the accompanied increase in ROS levels after RA induction that activates a 
canonical Wnt pathway, and that NRX and Dvl-2 show a redox dependant relationship, 
the idea must be put forth that NRX is an important regulator of Wnt signaling. As 
described earlier, in the presence of a canonical Wnt, Dvl is recruited to the plasma 
membrane and the levels of cytoplasmic β-catenin increase by virtue of the fact that its 
destruction complex (involving GSK-3β, Axin and APC) can no longer function.  The β-
catenin pool in the cytoplasm increases and some translocates into the nucleus where, 
with TCF-LEF, the complex imparts changes to Wnt target genes. Funato et al. (2006) 
examined the ability of NRX to induce activation of TCF using a luciferase reporter gene 
assay. Dvl overexpression led to increased levels of TCF activity, while the expression of 
TCF was completely suppressed by co-expression of NRX. Furthermore, TCF activity 
was upregulated in cells expressing an NRX RNAi [31]. In F9 cells, the nuclear 
accumulation of β-catenin and its interaction with TCF-LEF is obligatory for PrE 
differentiation [41]. Although my study did not utilize a reporter assay, the NRX 
knockdown did result in a significant increase in the level of TROMA-1 staining on 
immunoblots, reminiscent of RA-induced differentiation. Taken together, this 
demonstrates that the knockdown of NRX alone is sufficient to induce differentiation. 
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Furthermore, knocking down NRX and increasing cAMP levels in the absence of RA, led 
to a significant increase in TM, indicating the cells were competent and had differentiated 
to PE. Thus given my data and the evidence from the literature, I propose that in the 
absence of NRX, Dvl is not inhibited. In this free form, Dvl is thus recruited to the 
plasma membrane where it serves to prevent the destruction complex from targeting β-
catenin for proteasomal degradation. If this prediction is correct, then Dvl should be seen 
at or near the plasma membrane; likewise, examining TOPFlash reporter activity in cells 
transfected with the sh-NRX would also corroborate my prediction.   
 
4.5 Relationship of NRX and Nox point to future research 
in F9 cells 
 
Overall, the data presented provide compelling evidence that NRX plays an 
important role as a negative regulator of Wnt signaling in F9 teratocarcinoma cells. In our 
model the redox regulation of NRX is imperative in controlling Wnt signaling, which 
would take into account the increase in the levels of ROS following RA treatment (Fig. 
4.1). In this manner, the increase in ROS is predicted to modulate the conformation of 
NRX, thereby releasing Dvl and allowing it to participate in the transduction of the Wnt 
signal necessary for PrE differentiation. Although it is easy to envision that NRX serves 
as a failsafe mechanism to prevent aberrant Wnt signaling, the question remains as to the 
source of ROS. Candidates include the Nox family of ROS producing enzymes, 
consisting of Nox1-4 and Duox2, that are present in F9 cells [18]. In support of this idea 
our lab has shown that RA-induced differentiation is hindered when F9 cells are treated 
with the Nox inhibitor DPI [18]. This study also revealed that the Nox1–4 and Duox2 
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genes are RA-responsive. Nox4 has been linked to cell proliferation, migration and stem 
cell differentiation [44, 45], and that the Nox1 promoter is known to be regulated by 
Gata6, a master regulator of ExE [46]. Furthermore, studies using intestinal cells showed 
overexpressing NRX blocks Wnt-induced accumulation of β-catenin, however, 
overexpressing NRX and coexpressing Nox1 had the reverse effect [47]. Although these 
studies are encouraging and supportive, at present we do not know which of the Nox 
enzymes are responsible for producing the burst of ROS that is seen in F9 cells following 
exposure to RA. 
Despite not knowing the source that produces the ROS in response to RA, it is 
important to note that the regulation of these levels in the cell is essential since high 
levels of ROS and aberrant Wnt signaling are frequently demonstrated in cancer cells 
[43]. This NRX related redox regulation could have significant implications in 
understanding Wnt-dependent carcinogenesis. Towards that end, this study not only 
provides insight into how extraembryonic endoderm differentiates in the mammalian 
embryo, but it also gives us a better understanding of the relationship between ROS and 
the aberrant activation of signal transduction pathways involved in human 
pathophysiology.  
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Figure 4.1 A model for the differentiation of extraembryonic endoderm in F9 cells. RA 
acts through binding to RA receptors and retinoid X receptors which efficiently bind RA-
response elements in the promoter regions of target genes. RA induces the expression of 
Nox, leading to the production of intracellular H2O2. This increase in H2O2 levels cause 
NRX to form a disulfide bridge changing conformation and causing the release of bound 
Dvl-2. This in turn with binding of Wnt6 to the Fzd receptor causes Dvl-2 to be recruited 
to the plasma membrane where it acts to destabilize the destruction complex causing an 
increase of β-catenin in the cytosol, subsequent translocation to the nucleus where it 
binds to TCF-LEF to alter gene expression necessary for differentiation to 
extraembryonic endoderm. 
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